PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHiv infections
MeSH D015658 - hiv infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015229:Viral sexually transmitted diseases
0 Companies
0 Drugs
Success rate
D000086982:Blood-borne infections
0 Companies
0 Drugs
Success rate
D007153:Immunologic deficiency syndromes
$
Success rate
D016180:Lentivirus infections
0 Companies
0 Drugs
Success rate
D015658: 
Hiv infections
D000071297:Acute retroviral syndrome
0 Companies
0 Drugs
Success rate
D000163:Acquired immunodeficiency syndrome
D000386:Aids-related complex
0 Companies
0 Drugs
Success rate
D006679:Hiv seropositivity
0 Companies
0 Drugs
Success rate
D015526:Aids dementia complex
0 Companies
0 Drugs
Success rate
D016263:Aids-associated nephropathy
0 Companies
0 Drugs
Success rate
D019053:Hiv enteropathy
0 Companies
0 Drugs
Success rate
D019247:Hiv wasting syndrome
0 Companies
0 Drugs
Success rate
D020943:Central nervous system aids arteritis
0 Companies
0 Drugs
Success rate
D039682:Hiv-associated lipodystrophy syndrome
$
Success rate
D017088:Aids-related opportunistic infections
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieLopinavir, Ritonavir Kaletra  2001-03-19 $291 M Q2/19-Q1/20 
Ritonavir Norvir  1996-08-25 $165 M Q1/12-Q1/13 
AlvogenNevirapine Nevirapine  2015-07-10   
American RegentZidovudine Zidovudine  2010-05-06   
Amneal PharmaceuticalsEmtricitabine, Tenofovir disoproxil Emtricitabine Tenofovir Disoproxil  2018-08-22   
Etravirine Etravirine  2021-06-14   
Annora PharmaLamivudine Lamivudine  2019-03-21   
ApotexAbacavir Abacavir  2012-12-17   
Emtricitabine, Tenofovir disoproxil Emtricitabine Tenofovir Disoproxil  2021-06-16   
Lamivudine Lamivudine  2011-12-02   
Nevirapine Nevirapine  2012-05-22   
Aurobindo PharmaAbacavir Abacavir  2012-12-17   
Lamivudine, Abacavir Abacavir Lamivudine  2018-11-15   
Didanosine Didanosine  2012-08-14   
Efavirenz Efavirenz  2018-09-21   
Emtricitabine, Tenofovir disoproxil, Efavirenz Efavirenz, Emtricitabine, Tenofovir Disoproxil  2018-09-04   
Tenofovir disoproxil, Efavirenz, Lamivudine Efavirenz, Lamivudine Tenofovir Disoproxil  2018-08-15   
Emtricitabine, Tenofovir disoproxil Emtricitabine Tenofovir Disoproxil  2018-01-26   
Lamivudine Lamivudine  2016-11-21   
Tenofovir disoproxil, Lamivudine Lamivudine Tenofovir Disoproxil  2018-05-15   
Lamivudine, Zidovudine Lamivudine Zidovudine  2017-05-05   
Nevirapine Nevirapine  2012-05-22   
Stavudine Stavudine  2008-12-29   
Zidovudine Zidovudine  2005-09-19   
Emtricitabine Emtricitabine  2023-03-15   
Barr PharmaceuticalsDidanosine Didanosine  2004-12-03   
Boehringer IngelheimTipranavir Aptivus  2005-10-25   
Nevirapine Viramune  1996-06-21   
Breckenridge PharmaceuticalLamivudine Lamivudine  2016-11-21   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
76%
187/245
Phase 2
57%
173/302
Phase 3
53%
143/272
Approved: 58Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use